Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K Kuliczkowski
Addition of Cladribine to Daunorubicin and Cytarabine Increases Complete Remission Rate After a Single Course of Induction Treatment in Acute Myeloid Leukemia. Multicenter, Phase III Study
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
A Phase I Study of Selinexor in Combination With High-Dose Cytarabine and Mitoxantrone for Remission Induction in Patients With Acute Myeloid Leukemia
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
Correction To: Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
Drugs
Pharmacology
Dose Intensification of Daunorubicin and Cytarabine During Treatment of Adult Acute Lymphoblastic Leukemia
Cancer
Cancer Research
Oncology
Kinetics of Bone Marrow Blasts During Induction and Achievement of Complete Remission in Acute Myeloid Leukemia
Haematologica
Hematology
A Randomized Trial of High-Versus Conventional-Dose Cytarabine in Consolidation Chemotherapy for Adult De Novo Acute Myeloid Leukemia in First Remission After Induction Therapy Containing High-Dose Cytarabine
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Analysis of Transplantation Rate and Overall Treatment Efficacy by Age for Patients Aged 60 to 75 With Untreated Secondary Acute Myeloid Leukemia (AML) Given CPX-351 Liposome Injection Versus Conventional Cytarabine and Daunorubicin in a Phase III Trial
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Cytarabine Dose for Acute Myeloid Leukemia
New England Journal of Medicine
Medicine
Spontaneous Remission of Acute Myeloid Leukemia – A Single Center Case Reports
Klinicka Onkologie
Oncology
